← Back to Search

MRI Evaluation for Spinal Cord Injury (CHASM Trial)

N/A
Recruiting
Led By Brian Kwon, MD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Acute tSCI injury involving bony spinal levels between C0 and T1
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up injury to 6 months post injury
Awards & highlights

CHASM Trial Summary

This trial will test whether drugs to raise blood pressure and prevent blood clots can improve outcomes for people with traumatic spinal cord injuries.

Who is the study for?
This trial is for adults aged 19 or older who have suffered a traumatic spinal cord injury between the base of the skull and top of the chest (C0-T1) and are admitted to the study site within a day. They must be able to consent and have certain levels of impairment. Those with MRI-incompatible devices, very high BMI, incomplete assessments, injuries from infection or cancer, or multiple severe injuries can't join.Check my eligibility
What is being tested?
The study uses MRI scans to see if treatments right after a spinal cord injury affect bleeding in the spine. It looks at two things: whether raising blood pressure with drugs (vasopressors) and preventing blood clots with anticoagulants influence hemorrhage during the first two weeks post-injury.See study design
What are the potential side effects?
MRI itself doesn't usually cause side effects but lying still in a scanner might be uncomfortable for some people. The focus here is on observing changes rather than direct side effects from interventions like vasopressors or anticoagulants.

CHASM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My spinal injury is between the base of my skull and the top of my mid-back.

CHASM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~injury to 6 months post injury
This trial's timeline: 3 weeks for screening, Varies for treatment, and injury to 6 months post injury for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hemorrhage Quantification 1
Hemorrhage Quantification 2
Hemorrhage Quantification 3
+1 more
Secondary outcome measures
Hemodynamic Management Assessment 1
Hemodynamic Management Assessment 2
Other outcome measures
Neurologic Assessments

CHASM Trial Design

1Treatment groups
Experimental Treatment
Group I: Arm 1Experimental Treatment1 Intervention
Serial MRI scans of patients with acute cervical SCI to quantify hemorrhage.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic resonance imaging (MRI)
2019
Completed Phase 4
~1080

Find a Location

Who is running the clinical trial?

University of British ColumbiaLead Sponsor
1,415 Previous Clinical Trials
2,466,992 Total Patients Enrolled
United States Department of DefenseFED
863 Previous Clinical Trials
227,608 Total Patients Enrolled
Brian Kwon, MDPrincipal InvestigatorUniversity of British Columbia
3 Previous Clinical Trials
130 Total Patients Enrolled

Media Library

Magnetic resonance imaging (MRI) Clinical Trial Eligibility Overview. Trial Name: NCT04758377 — N/A
Spinal Cord Hemorrhage Research Study Groups: Arm 1
Spinal Cord Hemorrhage Clinical Trial 2023: Magnetic resonance imaging (MRI) Highlights & Side Effects. Trial Name: NCT04758377 — N/A
Magnetic resonance imaging (MRI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04758377 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have been enlisted in this research endeavor?

"Confirmed. Per the clinicaltrials.gov records, this clinical trial has been open for recruitment since February 6th 2021 and was last updated on February 7th 2022. 24 participants are needed to be recruited from 1 site location."

Answered by AI

Is enrollment currently open for this research endeavor?

"According to the clinicaltrials.gov listing, this study is currently in search of participants. It was first published on February 6th 2021 and underwent its most recent revision a year later on February 7th 2022."

Answered by AI
~1 spots leftby Jun 2024